Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors Journal Article


Authors: Dinh, P. C. Jr; Monahan, P. O.; Fung, C.; Sesso, H. D.; Feldman, D. R.; Vaughn, D. J.; Hamilton, R. J.; Huddart, R.; Martin, N. E.; Kollmannsberger, C.; Althouse, S.; Einhorn, L. H.; Frisina, R.; Root, J. C.; Ahles, T. A.; Travis, L. B.
Article Title: Cognitive function in long-term testicular cancer survivors: Impact of modifiable factors
Abstract: No study has comprehensively examined associated factors (adverse health outcomes, health behaviors, and demographics) affecting cognitive function in long-term testicular cancer survivors (TC survivors). TC survivors given cisplatin-based chemotherapy completed comprehensive, validated surveys, including those that assessed cognition. Medical record abstraction provided cancer and treatment history. Multivariable logistic regression examined relationships between potential associated factors and cognitive impairment. Among 678 TC survivors (median age = 46; interquartile range [IQR] = 38-54); median time since chemotherapy = 10.9 years, IQR = 7.9-15.9), 13.7% reported cognitive dysfunction. Hearing loss (odds ratio [OR] = 2.02; P =. 040), neuropathic pain (OR = 2.06; P =. 028), fatigue (OR = 6.11; P <. 001), and anxiety/depression (OR = 1.96; P =. 029) were associated with cognitive impairment in multivariable analyses. Being on disability (OR = 9.57; P =. 002) or retired (OR = 3.64; P =. 029) were also associated with cognitive decline. Factors associated with impaired cognition identify TC survivors requiring closer monitoring, counseling, and focused interventions. Hearing loss, neuropathic pain, fatigue, and anxiety/depression constitute potential targets for prevention or reduction of cognitive impairment in long-term TC survivors. © 2024 The Author(s).
Keywords: adult; controlled study; middle aged; major clinical study; fatigue; cisplatin; cancer survivor; depression; cognition; cognitive defect; anxiety; testis cancer; neuropathic pain; hearing impairment; human; male; female; article
Journal Title: JNCI Cancer Spectrum
Volume: 8
Issue: 5
ISSN: 2515-5091
Publisher: Oxford University Press  
Date Published: 2024-10-01
Start Page: pkae068
Language: English
DOI: 10.1093/jncics/pkae068
PUBMED: 39141447
PROVIDER: scopus
PMCID: PMC11424079
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tim A Ahles
    182 Ahles
  2. James Charles Root
    113 Root
  3. Darren Richard Feldman
    340 Feldman